Masaomi Nangaku

37.1k total citations · 8 hit papers
712 papers, 24.1k citations indexed

About

Masaomi Nangaku is a scholar working on Nephrology, Molecular Biology and Hematology. According to data from OpenAlex, Masaomi Nangaku has authored 712 papers receiving a total of 24.1k indexed citations (citations by other indexed papers that have themselves been cited), including 313 papers in Nephrology, 154 papers in Molecular Biology and 106 papers in Hematology. Recurrent topics in Masaomi Nangaku's work include Chronic Kidney Disease and Diabetes (114 papers), Dialysis and Renal Disease Management (111 papers) and Renal Diseases and Glomerulopathies (82 papers). Masaomi Nangaku is often cited by papers focused on Chronic Kidney Disease and Diabetes (114 papers), Dialysis and Renal Disease Management (111 papers) and Renal Diseases and Glomerulopathies (82 papers). Masaomi Nangaku collaborates with scholars based in Japan, United States and United Kingdom. Masaomi Nangaku's co-authors include Tetsuhiro Tanaka, Reiko Inagi, Toshiro Fujita, Toshio Miyata, Imari Mimura, William G. Couser, Kiyoshi Kurokawa, Akira Nishiyama, Hiroyuki Kobori and L. Gabriel Navar and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Masaomi Nangaku

662 papers receiving 23.8k citations

Hit Papers

The Intrarenal Renin-Angiotensin System: From Physiology ... 2005 2026 2012 2019 2007 2005 2019 2024 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
    2007 931 citations Masaomi Nangaku et al. profile →
  2. Chronic Hypoxia and Tubulointerstitial Injury
    2005 910 citations Masaomi Nangaku Journal of the American Society of Nephrology profile →
  3. Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury
    2019 419 citations Tetsuhiro Tanaka, Masaomi Nangaku et al. profile →
  4. Chronic kidney disease and the global public health agenda: an international consensus
    2024 387 citations Masaomi Nangaku, Vivekanand Jha et al. profile →
  5. Progression after AKI
    2015 341 citations Masaomi Nangaku et al. Journal of the American Society of Nephrology profile →
  6. Treatment of Diabetic Kidney Disease: Current and Future
    2021 169 citations Tetsuhiro Tanaka, Masaomi Nangaku et al. profile →
  7. Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
    2025 44 citations Rajiv Agarwal, Jennifer B. Green et al. New England Journal of Medicine profile →
  8. Chronic kidney disease
    2025 36 citations Rajiv Agarwal, Adeera Levin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaomi Nangaku Japan 82 8.4k 6.9k 3.2k 3.1k 2.8k 712 24.1k
Alberto Ortíz Spain 85 9.8k 1.2× 8.7k 1.2× 2.4k 0.8× 2.3k 0.8× 1.1k 0.4× 847 28.9k
Kai‐Uwe Eckardt Germany 86 11.1k 1.3× 7.3k 1.0× 2.5k 0.8× 5.1k 1.7× 5.8k 2.0× 486 33.5k
Hermann Haller Germany 80 4.4k 0.5× 7.0k 1.0× 3.5k 1.1× 2.0k 0.7× 1.4k 0.5× 454 23.0k
Hirofumi Makino Japan 74 6.6k 0.8× 7.0k 1.0× 3.9k 1.2× 1.2k 0.4× 1.2k 0.4× 672 23.6k
Agnes B. Fogo United States 86 10.1k 1.2× 7.1k 1.0× 3.2k 1.0× 1.0k 0.3× 958 0.3× 501 23.7k
Jesús Egido Spain 91 7.1k 0.8× 10.6k 1.5× 3.0k 1.0× 3.6k 1.2× 1.1k 0.4× 621 31.6k
Danilo Fliser Germany 75 6.6k 0.8× 4.0k 0.6× 1.7k 0.5× 993 0.3× 1.3k 0.5× 301 18.6k
Ton J. Rabelink Netherlands 81 3.9k 0.5× 7.1k 1.0× 3.5k 1.1× 1.7k 0.6× 1.0k 0.4× 542 25.9k
Jürgen Floege Germany 78 12.3k 1.5× 4.5k 0.6× 1.5k 0.5× 605 0.2× 1.6k 0.6× 412 21.0k
Florian Kronenberg Austria 73 4.2k 0.5× 4.7k 0.7× 3.6k 1.1× 2.0k 0.7× 660 0.2× 380 20.4k

Countries citing papers authored by Masaomi Nangaku

Since Specialization
Citations

This map shows the geographic impact of Masaomi Nangaku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaomi Nangaku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaomi Nangaku more than expected).

Fields of papers citing papers by Masaomi Nangaku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaomi Nangaku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaomi Nangaku. The network helps show where Masaomi Nangaku may publish in the future.

Co-authorship network of co-authors of Masaomi Nangaku

This figure shows the co-authorship network connecting the top 25 collaborators of Masaomi Nangaku. A scholar is included among the top collaborators of Masaomi Nangaku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaomi Nangaku. Masaomi Nangaku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelly, Dearbhla, Erika Jones, Silvia Arruebo, et al.. (2025). Global availability of medications and health technologies for kidney care: A multinational study from the ISN-GKHA. PLOS Global Public Health. 5(2). e0004268–e0004268. 1 indexed citations
2.
Agarwal, Rajiv, Jennifer B. Green, Hiddo J.L. Heerspink, et al.. (2025). Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. New England Journal of Medicine. 393(6). 533–543. 44 indexed citations breakdown →
3.
Okada, Akira, Hidehiro Kaneko, Tatsuhiko Azegami, et al.. (2025). Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims database. Diabetes Obesity and Metabolism. 28(1). 701–710.
4.
Imaizumi, Takahiro, Hirotaka Komaba, Takayuki Hamano, et al.. (2025). Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study. Clinical Kidney Journal. 18(2). sfae398–sfae398. 3 indexed citations
5.
Kaneko, Hidehiro, Yuta Suzuki, Akira Okada, et al.. (2025). Effect of SGLT2i on kidney outcomes of individuals with type 2 diabetes according to body mass index: nationwide cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 11(2). 155–163. 4 indexed citations
6.
Tungsanga, Somkanya, Silvia Arruebo, Fergus Caskey, et al.. (2024). Landscape of kidney replacement therapy provision in low- and lower-middle income countries: A multinational study from the ISN-GKHA. SHILAP Revista de lepidopterología. 4(12). e0003979–e0003979. 3 indexed citations
7.
Shinzawa, Maki, Isao Matsui, Yohei Doi, et al.. (2024). A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in Japan. Kidney International. 107(3). 530–540. 6 indexed citations
8.
Sugawara, Yuka, et al.. (2024). Coronavirus disease 2019 vaccination effectiveness based on the 2021 Japanese dialysis registry. Nephrology. 29(10). 671–679. 2 indexed citations
9.
Yeung, Emily K., Silvia Arruebo, Sandrine Damster, et al.. (2024). A global overview of health system financing and available infrastructure and oversight for kidney care. Nephrology Dialysis Transplantation. 39(Supplement_2). ii3–ii10. 2 indexed citations
10.
Ishii, Taisuke, Tetsuhiro Tanaka, & Masaomi Nangaku. (2022). Is HIF activation Janus faced? The therapeutic effects of the HIF-2α inhibitor. Kidney International. 101(5). 866–869. 1 indexed citations
11.
Yamaguchi, Satoko, Akira Okada, Shinji Sunaga, et al.. (2022). Impact of COVID-19 pandemic on healthcare service use for non-COVID-19 patients in Japan: retrospective cohort study. BMJ Open. 12(4). e060390–e060390. 38 indexed citations
12.
13.
Nangaku, Masaomi, et al.. (2020). Safety and Efficacy of Canagliflozin, an SGLT2 Inhibitor, in Patients with Type 2 Diabetes Mellitus-The Interim Analysis of Post-marketing Surveillance (SAPPHIRE), Third Report-. 69(3). 288–329. 2 indexed citations
14.
Fukui, Kenji, Yuichi Shinozaki, Takuya Matsui, et al.. (2019). JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor. European Journal of Pharmacology. 859. 172532–172532. 33 indexed citations
15.
Shoji, Kumi, Tetsuhiro Tanaka, & Masaomi Nangaku. (2013). Role of hypoxia in progressive chronic kidney disease and implications for therapy. Current Opinion in Nephrology & Hypertension. 23(2). 161–168. 59 indexed citations
16.
Nangaku, Masaomi, Christian Rosenberger, Samuel N. Heyman, & Kai‐Uwe Eckardt. (2012). Regulation of hypoxia‐inducible factor in kidney disease. Clinical and Experimental Pharmacology and Physiology. 40(2). 148–157. 106 indexed citations
17.
Chiang, Chih‐Kang, Masaomi Nangaku, Tetsuhiro Tanaka, Takao Iwawaki, & Reiko Inagi. (2012). Endoplasmic reticulum stress signal impairs erythropoietin production: a role for ATF4. American Journal of Physiology-Cell Physiology. 304(4). C342–C353. 38 indexed citations
18.
Ohtomo, Satoru, Masaomi Nangaku, Y. Izuhara, et al.. (2007). Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrology Dialysis Transplantation. 23(4). 1166–1172. 121 indexed citations
19.
Tanaka, Toshiaki, Hideki Kato, Ichiro Kojima, et al.. (2006). Hypoxia and Expression of Hypoxia-Inducible Factor in the Aging Kidney. The Journals of Gerontology Series A. 61(8). 795–805. 79 indexed citations
20.
Nangaku, Masaomi. (2006). The Heat Is On. Journal of the American Society of Nephrology. 18(1). 13–15. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Ortíz Breakdown of academic impact, for papers by Kai‐Uwe Eckardt Breakdown of academic impact, for papers by Hermann Haller Breakdown of academic impact, for papers by Hirofumi Makino Breakdown of academic impact, for papers by Agnes B. Fogo Breakdown of academic impact, for papers by Jesús Egido Breakdown of academic impact, for papers by Danilo Fliser Breakdown of academic impact, for papers by Ton J. Rabelink Breakdown of academic impact, for papers by Jürgen Floege Breakdown of academic impact, for papers by Florian Kronenberg
Rankless by CCL
2026